Kimberly-Clark Corporation
116.72-3.94 (-3.27%)
Oct 29, 4:00:02 PM EDT · NasdaqGS · KMB · USD
Key Stats
Market Cap
38.73BP/E (TTM)
15.97Basic EPS (TTM)
7.31Dividend Yield
0.04%Recent Filings
8-K
Q2 organic sales up 3.9%
Kimberly-Clark reported Q2 2025 net sales of $4.2 billion, down 1.6% from last year due to divestitures and currency headwinds, yet organic sales surged 3.9% on 5.0% volume growth from innovations. Adjusted EPS dipped 2.0% to $1.92 amid transformation costs, but the company raised its full-year outlook for low-to-mid single-digit growth in adjusted operating profit and EPS on a constant-currency basis. Powering Care strategy fuels market share gains. Risks include tariff impacts and IFP joint venture delays.
10-Q
Q2 FY2025 results
Kimberly-Clark's Q2 net sales dipped 1.6% year-over-year to $4.2B, yet operating profit climbed 9.8% to $592M, buoyed by volume gains and productivity savings amid the 2024 Transformation Initiative's $122M charges. Gross margin slipped to 35.0% from transformation costs and tariff pressures, but adjusted figures show underlying resilience with organic sales up 3.9%. Cash from operations fell to $1.1B year-to-date, supporting $401M capex and $120M share repurchases, while total debt eased to $7.2B with $634M cash on hand. The pending IFP joint venture, set for mid-2026 with Suzano for $1.7B, sharpens focus on core segments. North America and IPC drove gains, but currency headwinds linger. Solid margins persist. Regulatory hurdles could delay the IFP deal.
8-K
IFP JV recast as discontinued
Kimberly-Clark recast its financials to treat the International Family Care and Professional business as discontinued operations, reflecting a strategic shift ahead of its joint venture with Suzano. Announced June 5, 2025, the deal sees Suzano acquiring 51% for $1.7 billion in mid-2026, while Kimberly-Clark keeps 49%. This sharpens focus on core segments, boosting 2024 continuing operations income to $2,192 million from $1,459 million in 2023. Closing hinges on regulatory nods.
8-K
JV with Suzano for tissue business
Kimberly-Clark announced a joint venture with Suzano on June 5, 2025, divesting 51% of its international tissue and professional products business for $1.7 billion, retaining 49% ownership. The deal, covering $3.3 billion in 2024 net sales across 70+ countries and 22 facilities, sharpens focus on higher-growth personal care segments while unlocking efficiencies through Suzano's fiber expertise. Closing is slated for mid-2026, pending approvals. It expects $0.30-0.40 EPS dilution in year one, offset by share repurchases. Risks include regulatory hurdles and integration disruptions.
8-K
Nasdaq listing switch announced
Kimberly-Clark notified the NYSE on May 19, 2025, of its plan to voluntarily delist its common stock and shift listing to Nasdaq, with NYSE trading ending May 29 and Nasdaq commencing May 30 under the KMB symbol. The board also amended bylaws that day to excise NYSE-specific committee details, aligning with the transition. Smooth sailing expected. Yet risks like implementation delays or market hiccups could disrupt trading.
IPO
Employees
Sector
Industry
CL
Colgate-Palmolive Company
75.73-1.41
CLX
Clorox Company (The)
110.67-4.55
COTY
Coty Inc.
3.95-0.07
EL
Estee Lauder Companies, Inc. (T
97.36-1.40
HNST
The Honest Company, Inc.
3.46-0.14
KVUE
Kenvue Inc.
14.31-0.20
NWL
Newell Brands Inc.
4.93-0.07
PG
Procter & Gamble Company (The)
148.77-2.60
PKG
Packaging Corporation of Americ
196.65-9.51
UL
Unilever PLC
60.97-0.95